Miller Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Miller Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6K	Hold	100	–	–	0.01%	78
2026 Q1	$13.9K	Hold	100	–	–	0.01%	67
2025 Q4	$12.3K	Hold	100	–	–	﹤0.01%	72
2025 Q3	$11.1K	Hold	100	–	–	﹤0.01%	73
2025 Q2	$11.1K	Hold	100	–	–	0.01%	64
2025 Q1	$11.2K	Hold	100	–	–	0.01%	62
2024 Q4	$9.24K	Hold	100	–	–	﹤0.01%	59
2024 Q3	$8.74K	Hold	100	–	–	﹤0.01%	54
2024 Q2	$6.86K	Hold	100	–	–	﹤0.01%	60
2024 Q1	$7.33K	Hold	100	–	–	﹤0.01%	61
2023 Q4	$8.1K	Hold	100	–	–	0.01%	54
2023 Q3	$7.49K	Hold	100	–	–	0.01%	52
2023 Q2	$7.71K	Buy	100 +15	+18%	+$1.2K	0.01%	48
2023 Q1	$2K	Sell	85 -115	-58%	-$9.53K	0.01%	57
2022 Q4	$15K	Buy	200 +100	+100%	+$7.92K	0.01%	44
2022 Q3	$6K	Hold	100	–	–	﹤0.01%	71
2022 Q2	$6K	Hold	100	–	–	0.01%	63
2022 Q1	$6K	Hold	100	–	–	﹤0.01%	68
2021 Q4	$7K	Buy	+100	New	+$6.89K	﹤0.01%	67

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Miller Wealth Advisors's GILD Position: Q2 2026 in Review

Miller Wealth Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 100 shares worth $12.6K. The position accounts for 0.01% of the portfolio, ranked #78.

Miller Wealth Advisors first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $15K in Q4 2022. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Miller Wealth Advisors held 100 shares of Gilead Sciences worth $12.6K as of Q2 2026.
Miller Wealth Advisors left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.01% of Miller Wealth Advisors's portfolio in Q2 2026, its #78 holding.
Miller Wealth Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
Miller Wealth Advisors's Gilead Sciences position peaked at $15K in Q4 2022.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.